Spero Therapeutics, Inc. (SPRO)
2.41
+0.01
(+0.42%)
USD |
NASDAQ |
Jan 16, 16:00
2.39
-0.02
(-0.83%)
After-Hours: 20:00
Spero Therapeutics Profit Margin (Quarterly): -242.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Amicus Therapeutics, Inc. | 10.24% |
| Cassava Sciences, Inc. | -- |
| Omeros Corp. | -- |
| GeoVax Labs, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.0% |
| Return on Assets | -49.85% |
| Return on Invested Capital | -97.58% |
| Operating Margin (Quarterly) | -319.0% |
| Return on Net Operating Assets | -134.9% |